72 related articles for article (PubMed ID: 2238887)
1. Detection of circulating immune complexes in MRL mice with different forms of glomerulonephritis.
Hewicker M; Kromschröder E; Trautwein G
Z Versuchstierkd; 1990; 33(4):149-56. PubMed ID: 2238887
[TBL] [Abstract][Full Text] [Related]
2. [The pathogenesis of glomerulonephritis in MRL mice--murine lupus erythematosus].
Hewicker M; Kromschröder E; Trautwein G
Verh Dtsch Ges Pathol; 1989; 73():129-32. PubMed ID: 2482597
[TBL] [Abstract][Full Text] [Related]
3. Induction of various autoantibodies by mutant gene lpr in several strains of mice.
Izui S; Kelley VE; Masuda K; Yoshida H; Roths JB; Murphy ED
J Immunol; 1984 Jul; 133(1):227-33. PubMed ID: 6609979
[TBL] [Abstract][Full Text] [Related]
4. Nephritogenicity of the lprcg gene on the MRL background.
Kimura M; Ogata Y; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A
Immunology; 1992 Jul; 76(3):498-504. PubMed ID: 1526655
[TBL] [Abstract][Full Text] [Related]
5. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
[TBL] [Abstract][Full Text] [Related]
6. Arteritis in a novel congenic strain of mice derived from MRL/Lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody production.
Nose M; Nishimura M; Ito MR; Toh J; Shibata T; Sugisaki T
Am J Pathol; 1996 Nov; 149(5):1763-9. PubMed ID: 8909264
[TBL] [Abstract][Full Text] [Related]
7. Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice.
Miyawaki S; Nakamura Y; Takeshita T; Yoshida H; Shibata Y; Mitsuoka S
Lab Anim Sci; 1988 Jun; 38(3):266-72. PubMed ID: 2970562
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanisms of the development of lupus nephritis in BXSB mice. II. Comparative studies between male BXSB and MRL/lpr mice at the onset period.
Makino M; Fujiwara M; Watanabe H
J Clin Lab Immunol; 1988 Feb; 25(2):83-8. PubMed ID: 3259631
[TBL] [Abstract][Full Text] [Related]
9. Circulating and tissue immune complexes in mercury-treated mice.
Hultman P; Skogh T; Eneström S
J Clin Lab Immunol; 1989 Aug; 29(4):175-83. PubMed ID: 2534665
[TBL] [Abstract][Full Text] [Related]
10. Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse.
Itoh J; Nose M; Takahashi S; Ono M; Terasaki S; Kondoh E; Kyogoku M
Am J Pathol; 1993 Nov; 143(5):1436-43. PubMed ID: 8238259
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.
Licht R; van Bruggen MC; Oppers-Walgreen B; Rijke TP; Berden JH
Arthritis Rheum; 2001 Jun; 44(6):1320-30. PubMed ID: 11407691
[TBL] [Abstract][Full Text] [Related]
12. Studies on the role of the lpr gene in the development of immunological abnormalities and lupus nephritis. Analyses in F2 mice.
Fujiwara M; Kariyone A; Shiraki M
Clin Exp Immunol; 1985 Jan; 59(1):161-8. PubMed ID: 3918816
[TBL] [Abstract][Full Text] [Related]
13. Encephalitozoon cuniculi infection in MRL/MPJ-LPR (lymphoproliferation) mice.
Liu JJ; Shadduck JA
Lab Anim Sci; 1988 Dec; 38(6):685-8. PubMed ID: 3146668
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis of spontaneous chronic polyarthritis in MRL mice].
Hewicker M; Garcés LH; Kromschröder E; Trautwein G
Z Rheumatol; 1988; 47(4):219-26. PubMed ID: 3188680
[TBL] [Abstract][Full Text] [Related]
16. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice.
Gyotoku Y; Abdelmoula M; Spertini F; Izui S; Lambert PH
J Immunol; 1987 Jun; 138(11):3785-92. PubMed ID: 3495570
[TBL] [Abstract][Full Text] [Related]
17. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
Cruse JM; Lewis RE; Dilioglou S
Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362
[TBL] [Abstract][Full Text] [Related]
18. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
[TBL] [Abstract][Full Text] [Related]
19. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
[TBL] [Abstract][Full Text] [Related]
20. Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas(lpr) mice from early lethality.
Bullard DC; King PD; Hicks MJ; Dupont B; Beaudet AL; Elkon KB
J Immunol; 1997 Aug; 159(4):2058-67. PubMed ID: 9257874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
